Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:48 pm Purchase |
2022-12-31 | 13G | Lyra Therapeutics, Inc. LYRA |
Nantahala Capital Management LLC | 44,417 7.000% |
44,417 (New Position) |
Filing History |
| 2023-02-14 4:40 pm Purchase |
2022-12-31 | 13G | Lyra Therapeutics, Inc. LYRA |
Venrock Healthcare Capital Partners II, L.P. | 68,665 9.999% |
4 (+0.01%) |
Filing History |
| 2023-02-14 3:47 pm Sale |
2022-12-31 | 13G | Lyra Therapeutics, Inc. LYRA |
PURA VIDA INVESTMENTS LLC | 43,146 6.780% |
-12,496 (-22.46%) |
Filing History |
| 2023-02-13 4:23 pm Unchanged |
2022-12-31 | 13G | Lyra Therapeutics, Inc. LYRA |
INTERSOUTH PARTNERS VII L P | 14,764 2.300% |
0 (Unchanged) |
Filing History |
| 2023-02-07 5:05 pm Unchanged |
2022-12-31 | 13G | Lyra Therapeutics, Inc. LYRA |
Polaris Venture Partners V L.P. | 28,475 4.500% |
0 (Unchanged) |
Filing History |
| 2022-11-08 4:12 pm Purchase |
2022-05-20 | 13G | Lyra Therapeutics, Inc. LYRA |
PURA VIDA INVESTMENTS LLC | 55,642 8.740% |
55,642 (New Position) |
Filing History |
| 2022-04-22 4:20 pm Purchase |
2022-04-12 | 13D | Lyra Therapeutics, Inc. LYRA |
NBVM GP LLC | 84,376 13.200% |
50,097 (+146.15%) |
Filing History |
| 2022-04-22 4:05 pm Purchase |
2022-04-12 | 13G | Lyra Therapeutics, Inc. LYRA |
Venrock Healthcare Capital Partners II, L.P. | 68,661 9.999% |
68,661 (New Position) |
Filing History |
| 2022-04-14 5:10 pm Purchase |
2022-04-07 | 13D | Lyra Therapeutics, Inc. LYRA |
Perceptive Advisors LLC | 182,935 24.800% |
118,483 (+183.83%) |
Filing History |
| 2022-02-14 4:30 pm Sale |
2021-12-31 | 13G | Lyra Therapeutics, Inc. LYRA |
Ikarian Capital LLC | 7,891 3.000% |
-8,417 (-51.61%) |
Filing History |
| 2022-02-14 2:55 pm Sale |
2021-12-31 | 13G | Lyra Therapeutics, Inc. LYRA |
ArrowMark Colorado Holdings LLC | 0 0.000% |
-12,966 (Position Closed) |
Filing History |
| 2021-05-17 4:32 pm Sale |
2021-05-17 | 13G | Lyra Therapeutics, Inc. LYRA |
RA Capital Management, L.P. | 0 0.000% |
-16,317 (Position Closed) |
Filing History |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | Lyra Therapeutics, Inc. LYRA |
RA Capital Management, L.P. | 16,317 6.300% |
16,317 (New Position) |
Filing History |
| 2021-02-16 1:29 pm Purchase |
2020-12-31 | 13G | Lyra Therapeutics, Inc. LYRA |
ArrowMark Colorado Holdings LLC | 12,966 5.000% |
12,966 (New Position) |
Filing History |
| 2021-02-16 07:49 am Purchase |
2020-12-31 | 13G | Lyra Therapeutics, Inc. LYRA |
Ikarian Capital LLC | 16,307 6.300% |
600 (+3.82%) |
Filing History |
| 2021-02-12 5:10 pm Purchase |
2020-12-31 | 13G | Lyra Therapeutics, Inc. LYRA |
Polaris Venture Partners V L.P. | 28,475 11.000% |
28,475 (New Position) |
Filing History |
| 2021-02-12 4:16 pm Purchase |
2020-12-31 | 13G | Lyra Therapeutics, Inc. LYRA |
INTERSOUTH PARTNERS VII L P | 14,764 5.700% |
14,764 (New Position) |
Filing History |
| 2020-12-30 5:26 pm Purchase |
2020-12-15 | 13G | Lyra Therapeutics, Inc. LYRA |
Ikarian Capital LLC | 15,707 6.100% |
15,707 (New Position) |
Filing History |